NexPlasmaGen Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Later Stage VC
- (In Progress)
- Latest Deal Amount
-
$4M
- Investors
-
26
NexPlasmaGen General Information
Description
Developer of a cold plasma delivery system designed to reduce cancer recurrence. The company offers a cold plasma device that generates plasma species to produce cellular oxidative stress that kills cancer cells while sparing healthy tissue, enabling hospitals and cancer patients to reduce cancer recurrence and hospital costs and improve patient quality of life.
Contact Information
Website
www.nexplasmagen.comCorporate Office
- 3801 Wilson Avenue
- Montreal, Quebec H4A 2T7
- Canada
Corporate Office
- 3801 Wilson Avenue
- Montreal, Quebec H4A 2T7
- Canada
NexPlasmaGen Timeline
NexPlasmaGen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Later Stage VC | 11-Jul-2026 | $4M | In Progress | Clinical Trials - Phase 1 | ||
| 13. Later Stage VC | 13-Jul-2026 | Completed | Clinical Trials - Phase 1 | |||
| 12. Later Stage VC | 31-Dec-2024 | Completed | Product Development | |||
| 11. Angel (individual) | 31-Dec-2023 | Completed | Clinical Trials - Phase 1 | |||
| 10. Accelerator/Incubator | 04-May-2023 | Completed | Clinical Trials - Phase 1 | |||
| 9. Grant | 21-Apr-2023 | Completed | Clinical Trials - Phase 1 | |||
| 8. Grant | 31-Jan-2023 | Completed | Clinical Trials - Phase 1 | |||
| 7. Angel (individual) | 30-May-2022 | Completed | Clinical Trials - Phase 1 | |||
| 6. Grant | 01-Jan-2022 | $672K | $425K | Completed | Clinical Trials - Phase 1 | |
| 5. Seed Round | 31-Aug-2021 | $85K | $425K | Completed | Clinical Trials - Phase 1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
NexPlasmaGen Comparisons
Industry
Financing
Details
NexPlasmaGen Competitors (1)
One of NexPlasmaGen’s competitors is US Medical Innovations, a Private Equity-Backed company based in Takoma Park, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| US Medical Innovations | Private Equity-Backed | Takoma Park, MD |
NexPlasmaGen Patents
NexPlasmaGen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4824274-A1 | Plasma-based treatment of cancer | Pending | 10-Jun-2024 | ||
| WO-2025255650-A1 | Plasma-based treatment of cancer | Pending | 10-Jun-2024 | ||
| CA-3128262-A1 | Convertible plasma source and method | Active | 06-Aug-2019 | ||
| EP-3906755-A1 | Convertible plasma source and method | Pending | 06-Aug-2019 | ||
| EP-3906755-A4 | Convertible plasma source and method | Pending | 06-Aug-2019 | H05H1/245 |
NexPlasmaGen Signals
NexPlasmaGen Investors (26)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 9424-7517 Québec | Holding Company | Minority | ||
| Angel (individual) | Minority | |||
| MSBi Valorisation | Venture Capital | Minority | ||
| SWAN Impact Network | Angel Group | Minority | ||
| Campus des technologies de la santé | Accelerator/Incubator |
NexPlasmaGen FAQs
-
When was NexPlasmaGen founded?
NexPlasmaGen was founded in 2008.
-
Where is NexPlasmaGen headquartered?
NexPlasmaGen is headquartered in Montreal, Canada.
-
What is the size of NexPlasmaGen?
NexPlasmaGen has 2 total employees.
-
What industry is NexPlasmaGen in?
NexPlasmaGen’s primary industry is Therapeutic Devices.
-
Is NexPlasmaGen a private or public company?
NexPlasmaGen is a Private company.
-
What is NexPlasmaGen’s current revenue?
The current revenue for NexPlasmaGen is .
-
How much funding has NexPlasmaGen raised over time?
NexPlasmaGen has raised $1.03M.
-
Who are NexPlasmaGen’s investors?
9424-7517 Québec, , MSBi Valorisation, SWAN Impact Network, and Campus des technologies de la santé are 5 of 26 investors who have invested in NexPlasmaGen.
-
Who are NexPlasmaGen’s competitors?
US Medical Innovations is a competitor of NexPlasmaGen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process